{"id":18687,"date":"2026-09-22T09:34:21","date_gmt":"2026-09-22T07:34:21","guid":{"rendered":"https:\/\/www.interpharma.ch\/blog\/erkenntnisse\/neue-arzneimittel-fuer-die-schweiz\/"},"modified":"2026-11-04T11:42:38","modified_gmt":"2026-11-04T10:42:38","slug":"nouveaux-medicaments-pour-la-suisse","status":"publish","type":"steuerstudie","link":"https:\/\/www.interpharma.ch\/fr\/blog\/enseignements\/nouveaux-medicaments-pour-la-suisse\/","title":{"rendered":"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE"},"featured_media":18735,"menu_order":0,"template":"page-templates\/studie-report.php","class_list":["post-18687","steuerstudie","type-steuerstudie","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nNOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE - Interpharma<\/title>\n<meta name=\"description\" content=\"En 2025, Swissmedic a autoris\u00e9 40 nouvelles substances actives ainsi que 109 extensions d\u2019indication pour des m\u00e9dicaments d\u00e9j\u00e0 existants. Le Rapport sur l\u2019innovation montre o\u00f9 en est aujourd\u2019hui la recherche pharmaceutique suisse et ce que cela signifie pour les patientes et les patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE\" \/>\n<meta property=\"og:description\" content=\"En 2025, Swissmedic a autoris\u00e9 40 nouvelles substances actives ainsi que 109 extensions d\u2019indication pour des m\u00e9dicaments d\u00e9j\u00e0 existants. Le Rapport sur l\u2019innovation montre o\u00f9 en est aujourd\u2019hui la recherche pharmaceutique suisse et ce que cela signifie pour les patientes et les patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-04T10:42:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/\",\"name\":\"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE - Interpharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png\",\"datePublished\":\"2026-09-22T07:34:21+00:00\",\"dateModified\":\"2026-11-04T10:42:38+00:00\",\"description\":\"En 2025, Swissmedic a autoris\u00e9 40 nouvelles substances actives ainsi que 109 extensions d\u2019indication pour des m\u00e9dicaments d\u00e9j\u00e0 existants. Le Rapport sur l\u2019innovation montre o\u00f9 en est aujourd\u2019hui la recherche pharmaceutique suisse et ce que cela signifie pour les patientes et les patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png\",\"width\":1200,\"height\":627,\"caption\":\"40 nouvelles substances actives pour la Suisse. Il faut toutefois 219 jours en m\u00e9diane pour qu\u2019un nouveau m\u00e9dicament parvienne aux personnes concern\u00e9es.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/nouveaux-medicaments-pour-la-suisse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Studien\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/erkenntnisse\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE - Interpharma","description":"En 2025, Swissmedic a autoris\u00e9 40 nouvelles substances actives ainsi que 109 extensions d\u2019indication pour des m\u00e9dicaments d\u00e9j\u00e0 existants. Le Rapport sur l\u2019innovation montre o\u00f9 en est aujourd\u2019hui la recherche pharmaceutique suisse et ce que cela signifie pour les patientes et les patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/","og_locale":"fr_FR","og_type":"article","og_title":"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE","og_description":"En 2025, Swissmedic a autoris\u00e9 40 nouvelles substances actives ainsi que 109 extensions d\u2019indication pour des m\u00e9dicaments d\u00e9j\u00e0 existants. Le Rapport sur l\u2019innovation montre o\u00f9 en est aujourd\u2019hui la recherche pharmaceutique suisse et ce que cela signifie pour les patientes et les patients.","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/","og_site_name":"Interpharma","article_modified_time":"2026-11-04T10:42:38+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@interpharma_ch","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/","name":"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png","datePublished":"2026-09-22T07:34:21+00:00","dateModified":"2026-11-04T10:42:38+00:00","description":"En 2025, Swissmedic a autoris\u00e9 40 nouvelles substances actives ainsi que 109 extensions d\u2019indication pour des m\u00e9dicaments d\u00e9j\u00e0 existants. Le Rapport sur l\u2019innovation montre o\u00f9 en est aujourd\u2019hui la recherche pharmaceutique suisse et ce que cela signifie pour les patientes et les patients.","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/rapport-innovation-nouveaux-medicaments-image-apercu-fr-1.png","width":1200,"height":627,"caption":"40 nouvelles substances actives pour la Suisse. Il faut toutefois 219 jours en m\u00e9diane pour qu\u2019un nouveau m\u00e9dicament parvienne aux personnes concern\u00e9es."},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/nouveaux-medicaments-pour-la-suisse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Studien","item":"https:\/\/www.interpharma.ch\/blog\/erkenntnisse\/"},{"@type":"ListItem","position":3,"name":"NOUVEAUX M\u00c9DICAMENTS POUR LA SUISSE"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/18687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/steuerstudie"}],"version-history":[{"count":15,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/18687\/revisions"}],"predecessor-version":[{"id":18738,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/18687\/revisions\/18738"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/18735"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=18687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}